Excelya

Excelya is an independent European Contract Research Organization (CRO), founded in 2014 and run by engineers, François Moisson and Frédéric Paqueville. It provides full-service CRO, Functional Service Provider (FSP), and resourcing solutions to Biotech, Pharma, and Medical Device organizations. The company employs more than 1,000 experts and operates in 28 countries across Europe, the USA, and India.

The work spans clinical research and clinical trial management, including oncology research, late phase studies, and real world evidence. Excelya reports more than 550 clinical studies completed, among them 71 oncology studies in three years. Therapeutic coverage is organized around six core areas - Oncology & Hematology, Rare Disease & Pediatrics, Inflammation & Immunology, Infectious Disease & Vaccines, Pain Treatment & CNS, and Late Phase & Real World Evidence - with some 40 years of collective experience across them.

Delivery takes three forms: end-to-end bespoke clinical trial solutions under the full-service model, a functional outsourcing model that combines flexibility with therapeutic expertise, and staffing and resourcing services for clinical research organizations. The company describes itself as a one-stop provider built on collaborative partnerships and a patient-centered approach, guided by the values of Energy, Care, and Audacity.